Where can I read published information about N-acetylcarnosine?

The following links will take you to some of the articles that have discussed N-acetylcarnosine.

NAC: Is it the cure for cataract?
Article that appeared in the Antiaging Bulletin.

The breakthrough eye-drops for cataract
Interview with Mark Babizhayev Ph.D. that appeared in the International Antiaging Magazine.

The need for purity and precise formula in the development of N-acetylcarnosine eye-drops.
Interview with Mark Babizhayev Ph.D. that appeared in the International Antiaging Bulletin.

Lipid peroxidation as a possible cause of human cataracts. N-acetylcarnosine as a potent ophthalmic drug for the treatment of human cataracts.
Lecture by Mark Babizhayev Ph.D., at the International Monte Carlo Anti-Aging Conference.

The following links will take you to abstracts from international Journals that have published articles about the clinical effects and uses of N-acetylcarnosine.

Biological activities of the natural imidazole containing peptidomimetics n-acetylcarnosine, carcinine and l-carnosine in ophthalmic and skin care products.
Life Sciences 78 (2006) 2343-2357

Biological activities of the natural imidazole containing peptidomimetics n-acetylcarnosine, carcinine and l-carnosine in ophthalmic and skin care products.
Life Sciences 78 (2006) 2343-2357

Analysis of Lipid Peroxidation and Electron Microscopic Survey of Maturation Stages during Human Cataractogenesis: Pharmacokinetic Assay of Can-C (TM) N-Acetylcarnosine Prodrug Lubricant Eye Drops for Cataract Prevention
Drugs R&D: 2005;6(6):345-69

Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops.
Rejuvenation Res. 2004 Fall;7(3):186-98.

Lipid peroxidation and cataracts : N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.
Drugs R&D, 2004;5(3):125-39

Efficacy of N-acetylcarnosine in the treatment of cataracts.
Drugs R&D, 2002: 3(2): 87-103

N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts.
Peptides, Vol. 22 (6) (2001) pp. 979-994

Imidazole containing peptidomimetic NACA as a potent drug for the medicinal treatment of age-related cataract in humans.
Journal of Anti-Aging Medicine, Vol. 3 No. 1 43- 62, 2000.

The Natural Histidine-Containing Dipeptide N-alpha-Acetylcarnosine as an Antioxidant for Ophthalmic Use. Biochemistry, Volume 65 (2000) number 5

N-alpha-acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant.
Clin Chim Acta. 1996 Oct 15;254(1):1-21.

L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid peroxidase activities.
Biochem J. 1994 Dec 1;304 (Pt 2): 509-16.

Morphometric evaluation of human lens opacification.
J. Microc. 1989 May;154 (Pt 2):115-27.

Lipid peroxidation as a possible cause of cataract.
Mech. Ageing Dev., 1988 July, 44(1): pp69-89.